Cisplatin: from DNA damage to cancer chemotherapy
- PMID: 11525387
- DOI: 10.1016/s0079-6603(01)67026-0
Cisplatin: from DNA damage to cancer chemotherapy
Abstract
Cisplatin [cis-DDP, cis-diamminedichloroplatinum(II)] is a potent anticancer drug that has been used successfully to treat tumors of the head, neck, lungs, and genitourinary tract. The biological activity of cisplatin was discovered serendipitously more than 30 years ago, and since that time research efforts have focused on elucidating its mechanism of action. The present review provides a historical perspective of our attempts to understand this complex phenomenon and the results of recent work that guides our current activities in this field. Continued efforts to understand the mechanism of genotoxicity of cisplatin are expected to lead to the discovery of new drugs and combinations for the improvement of cancer chemotherapy.
Similar articles
-
Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.Met Ions Biol Syst. 1996;32:687-726. Met Ions Biol Syst. 1996. PMID: 8640535 Review. No abstract available.
-
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.Nature. 1999 Jun 17;399(6737):708-12. doi: 10.1038/21460. Nature. 1999. PMID: 10385126
-
The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13448-51. doi: 10.1073/pnas.94.25.13448. Proc Natl Acad Sci U S A. 1997. PMID: 9391045 Free PMC article.
-
Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.J Mol Biol. 1995 Feb 17;246(2):243-7. doi: 10.1006/jmbi.1994.0079. J Mol Biol. 1995. PMID: 7869375
-
Recognition of cisplatin adducts by cellular proteins.Mutat Res. 2001 Jul 1;478(1-2):1-21. doi: 10.1016/s0027-5107(01)00142-7. Mutat Res. 2001. PMID: 11406166 Review.
Cited by
-
Diazapyrenes: interaction with nucleic acids and biological activity.Chem Heterocycl Compd (N Y). 2020;56(6):674-693. doi: 10.1007/s10593-020-02717-1. Epub 2020 Jul 17. Chem Heterocycl Compd (N Y). 2020. PMID: 32836316 Free PMC article.
-
Diastereomeric bactericidal effect of Ru(phenanthroline)2 dipyridophenazine.Chirality. 2016 Nov;28(11):713-720. doi: 10.1002/chir.22656. Chirality. 2016. PMID: 27791316 Free PMC article.
-
Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells.Oncotarget. 2016 Jul 5;7(27):41320-41335. doi: 10.18632/oncotarget.9321. Oncotarget. 2016. PMID: 27191498 Free PMC article.
-
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.Biophys J. 2007 Dec 1;93(11):3950-62. doi: 10.1529/biophysj.107.116996. Epub 2007 Aug 17. Biophys J. 2007. PMID: 17704160 Free PMC article.
-
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.Bioconjug Chem. 2008 Jan;19(1):39-49. doi: 10.1021/bc070031k. Epub 2007 Sep 11. Bioconjug Chem. 2008. PMID: 17845003 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources